Ken Haas
Venture Partner

has spent 25 years in the management of both early-stage and public high technology and biotechnology companies. He was part of the founding management team at IntelliGenetics, one of the world’s first bioinformatics companies and, from 1992 to 2001, was CEO of IntelliCorp, a publicly-traded enterprise software company. At the beginning of his career he practised as an attorney in the business and technology group of Heller, Ehrman, White & McAuliffe, and has been Co-Chair of the Advisory Council to the Neuroscience Institute at Stanford. Ken’s directorships include Broncus Technologies, Gynesonics, Intellikine and Pathwork Diagnostics. He received his BA from Harvard College, an MA from the University of Sussex, a JD from Harvard Law School and attended the Advanced Management Program at Harvard Business School. Ken has been with Abingworth since 2004 and is based in Menlo Park.